APA (7th ed.) Citation

Owens, A. T., Desai, M., Wheeler, M. T., Rodonski, A., Merali, S., Sehnert, A. J., & Saberi, S. Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response. Wiley.

Chicago Style (17th ed.) Citation

Owens, Anjali T., Milind Desai, Matthew T. Wheeler, Anna Rodonski, Samira Merali, Amy J. Sehnert, and Sara Saberi. Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response. Wiley.

MLA (9th ed.) Citation

Owens, Anjali T., et al. Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response. Wiley.